Experts has a new look! Let us know what you think of the updates.

Provide feedback

Scholarly Works

INT 0123 (Radiation Therapy Oncology Group 94-05)...

Journal article

INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy

Authors

Minsky BD

Journal

Journal of Clinical Oncology, Vol. 20, No. 5, pp. 1167–1174

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

March 1, 2002

DOI

10.1200/jco.20.5.1167

ISSN

0732-183X

Associated Experts

Gordon Okawara

Associate Professor, Faculty of Health Sciences

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3202 Clinical Sciences 3211 Oncology and carcinogenesis

Sustainable Development Goals (SDG)

3 Good Health and Well Being

Medical Subject Headings (MeSH)

Adenocarcinoma Adult Aged Aged, 80 and over Carcinoma, Squamous Cell Combined Modality Therapy Esophageal Neoplasms Female Humans Male Middle Aged Neoplasm Recurrence, Local Radiotherapy Radiotherapy Dosage Treatment Outcome

View published work (Non-McMaster Users)

View published work (McMaster Users)